Прогнозування РНК, siRNA з подальшим визначенням імунологічної відповіді запропонованої вакцини (Vac534) проти COVID-19

Abstract

Despite the decline in Coronavirus infections, care must be taken to avoid new mutations that allow the virus to escape vaccination and treatment. Viral RNA is responsible for virus replication and assembly in the host cell. Aim. The goal of this work was to predict the RNA secondary structure of the vaccination we developed before (Vac534). In addition, the degree of RNA overlaps while translating into ribosomes, refolding, and evaluating the protein immune response are all considered. Methods. Different immunobioinformatics tools and servers were utilized for analysis. RNA folding was executed through the application of RNAstructure 6.4 and RNAfold software. The unique sequence context led to the emergence of potential RNA structures at the site where ribosome binding occurs. A new method, C-IMMSIM, which relies on immune cell epitope prediction, was employed to gain fresh insights into comprehending the immune system. Results. А high probability of ≥ 99% is shown between nucleotides with the stability of loops and motifs of the RNA 2D structure. The predicted siRNA sequences, which were located in three places, were used to calculate total energy, self-folding, and a free end with a high accessibility score. RNA translation into the ribosome is required to determine the optimum direction of translation. The short docking fragment of 24 nucleotides of RNA (Vac534) generated six robust binds with MPRO at high energy. Conclusions. The immunological evaluation of the vaccination is critical for stimulating immune cells and detecting interleukins and cytokine production. This study is viewed as a step toward developing Coronavirus treatments. The number of loops and motifs is increasing, with a probability of above 99% for most sequences. The predicted siRNA sequences, which were located in three places, were used to calculate total energy, self-folding, and a free end with a high accessibility score.